October 2013 Research Alert

This month we added six new studies to the Best Practice Database, the research repository for Best Practices, LLC. Four of the new studies deal with marketing multiple brands in the same therapeutic area - two of the studies present a pharma perspective on this issue while the other two studies are medical device oriented. Another new study revolves around the value of building a positive corporate brand. The last study is a published article authored by a Merck executive and Best Practices LLC's chief executive about business models that promote long-term survival.

The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.

If you would like to receive this monthly alert, sign-up here.

Newly Added Research

Click here to view abstracts for any of these new titles or paste the following link into your browser: http://www3.best-in-class.com/de2062.htm

Best Practice Database Documents

Best Practices in Marketing Multiple Brands in the Same Therapeutic Area: Marketing Spend and Activities (ID 5270)
Best Practices in Marketing Multiple Brands in the Same Therapeutic Area: Differentiating New & Legacy Products and Qualitative Insights (ID 5269)
Best Practices in Marketing Multiple Medical Device Products in the Same Therapeutic Area: Marketing Spend and Activities (ID 5272)
Best Practices in Marketing Multiple Medical Device Products in the Same Therapeutic Area: Differentiating New & Legacy Products and Qualitative Insights (ID 5271)
Best Practices in Building Your Corporate Value Proposition (ID 5268)
BioPharmaCo at 1000: New Business Models to Ensure Long-term Health, Prosperity & Survival (ID 5273)

Current Surveys

To view and participate in our current research studies, click or paste the following URL into your browser: http://www3.best-in-class.com/de382.htm to access the "Benchmark Studies" page. You can also access the studies below.

Study Title: Beyond BRIC: Mapping Pharma's Current and Future Emerging Market Frontier

Link to the Survey: http://www.surveygizmo.com/s3/1200742/Beyond-BRIC-Mapping-Pharma-s-Current-and-Future-Emerging-Market-Frontier

Objective: To identify current and recent trends relative to bio-pharmaceutical industry expansion into Emerging Markets. The research will identify the level of interest in regions beyond BRIC, successful strategies for entering these markets, investment levels by region, future growth prospects, and factors that affect decisions while entering Emerging Markets.
Study Title: Best Practices in Portfolio Management and Strategy

Link to the Survey: http://www.surveygizmo.com/s3/963510/Best-Practices-in-Portfolio-Management-and-Strategy-copy-June-25-2012

Objective: To deliver future sustainable growth an appropriate balance between portfolio of discovery, development and marketed products is critical. But with changing industry structure, reduced business growth rates and shrinking pipelines, the significance of portfolio management has significantly increased in the pharmaceutical industry.
Study Topic: Deploying the iPad or Android-Based Tablet to Sales and Managed Markets Teams: Benchmarking Training and Effectiveness

Link to the Survey: http://www.surveygizmo.com/s3/1387015/Deploying-the-iPad-or-Android-Based-Tablet-to-Medical-Science-Liaison-Teams-Benchmarking-Training-and-Effectiveness

Objective: This survey focuses on key challenges, lessons learned and best practices when deploying iPads or Android-Based tablets to large customer-facing commercial groups within BioPharma and Medical Device organizations.

ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE

Quick Links

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information

Need help finding anything?

Talk to a Best Practices representative.

October 2013 Research Alert